Lane & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $432K | Buy |
4,811
+170
| +4% | +$15.3K | 0.23% | 72 |
|
2024
Q4 | $459K | Sell |
4,641
-294
| -6% | -$29.1K | 0.24% | 68 |
|
2024
Q3 | $560K | Buy |
4,935
+1,689
| +52% | +$192K | 0.31% | 64 |
|
2024
Q2 | $402K | Buy |
3,246
+180
| +6% | +$22.3K | 0.24% | 73 |
|
2024
Q1 | $405K | Sell |
3,066
-1,363
| -31% | -$180K | 0.25% | 70 |
|
2023
Q4 | $483K | Sell |
4,429
-423
| -9% | -$46.1K | 0.35% | 60 |
|
2023
Q3 | $499K | Buy |
4,852
+179
| +4% | +$18.4K | 0.4% | 52 |
|
2023
Q2 | $539K | Buy |
4,673
+184
| +4% | +$21.2K | 0.43% | 48 |
|
2023
Q1 | $478K | Sell |
4,489
-638
| -12% | -$67.9K | 0.43% | 50 |
|
2022
Q4 | $569K | Buy |
+5,127
| New | +$569K | 0.54% | 44 |
|